AP

Alembic Pharmaceuticals LtdNSE APLLTD Stock Report

Last reporting period 31 Mar, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

1.328

Small

Exchange

XNSE - National Stock Exchange Of India

View Section: Price ratios

Alembic Statements

AP

Data from Alembic`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

INR - Indian rupee

Last reporting period:

31 Mar, 2024

Next reporting period:

27 Sep, 2024

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

05 Nov, 2024

Alembic Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

INR (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-03-31
%

31 475.5

2.2 %

100

8 401.3

25

23 074.2

4.6 %

75

0

7 511.3

26.5

19 199.3

-0.7 %

62.4

3 874.9

41.8 %

12.6

-261.6

-0.7

64.8

0.2

3 678.1

38.8 %

12.1

87.7

0.3

3 586.6

39.5 %

11.7

18.25

196.53

2023-09-30
%

30 810.8

5.7 %

100

8 749.5

28.9

22 061.3

8.8 %

71.1

0

6 951.6

21.8

19 329.4

13.2 %

62.2

2 731.9

-14.7 %

8.8

-300.8

-1

218.2

0.6

2 649.3

-9.5 %

8.5

72.3

-0.1

2 571.6

-6.3 %

8.6

13.09

196.45

2023-03-31
%

29 154.5

6.5 %

100

8 875

30.8

20 279.5

5.8 %

69.2

0

5 889.7

21.2

17 076.5

-5.3 %

59.4

3 204

184.8 %

9.8

-289.7

-1.02

12.8

0.06

2 927.1

215.4 %

8.9

-38.2

-2.6

2 745

306.7 %

10.9

13.952

196.93

2022-09-30
%

27 371

1.8 %

100

8 213

30

19 159

-2.2 %

70

0

5 802

19.6

18 033

2.6 %

58.8

1 125

-44.3 %

11.2

-212

-0.8

14

0.02

928

-60.9 %

10.4

165

1.2

675

-63.9 %

9

3.43

197

2022-03-31
%

26 874

2.6 %

100

7 285

27.3

19 590

3.1 %

72.8

0

5 500

19.6

17 570

16 %

72.6

2 020

-47.6 %

0.2

-110

-0.5

464

3.2

2 373

-38 %

2.9

308

-0.1

1 871

-43.9 %

0.8

9.52

196.5

2021-09-30
%

26 183

0.9 %

100

7 180

25.8

19 004

-4.4 %

74.2

0

5 831

22.7

15 150

4.1 %

58.6

3 854

-27.5 %

15.7

-67

-0.4

41

0.2

3 828

-37.3 %

15.5

737

3.1

3 338

-34.8 %

13.1

16.98

197

2021-03-31
%

25 947

-7.3 %

100

6 076

24.6

19 872

-7.5 %

75.4

0

4 997

18.5

14 558

5.2 %

58.8

5 313

-30.6 %

16.7

-49

-0.2

837

6.3

6 102

-19.5 %

22.8

1 136

4.3

5 117

-19.4 %

17.1

25.97

197

2020-09-30
%

27 984

15.8 %

100

6 498

21.4

21 487

15.9 %

78.6

0

5 515

18.9

13 832

7.5 %

51.2

7 656

35.1 %

27.4

-112

-0.3

35

0.2

7 579

39.8 %

27.3

1 398

5

6 349

38.4 %

22.9

33.59

189

2020-03-31
%

24 159

10.3 %

100

5 624

21.9

18 535

8.2 %

78.1

0

4 738

20.5

12 869

6 %

54.6

5 666

13.5 %

23.5

-152

-0.6

13

0.07

5 420

18.4 %

22

1 107

5.1

4 588

24 %

18.6

24.27

189

2019-09-30
%

21 898

12.6 %

100

4 770

22

17 128

15.7 %

78

0

4 327

17.6

12 137

8.5 %

53.1

4 991

38.1 %

24.9

-121

-0.6

37

0.03

4 579

28.2 %

24.4

885

4.2

3 700

25.9 %

19.8

19.59

189

2019-03-31
%

19 451

-2.2 %

100

4 652

23.4

14 799

1.2 %

76.6

0

3 991

21.7

11 187

5 %

60.7

3 613

-9 %

16

-111

-0.6

69

0.4

3 572

-8.9 %

15.8

549

1.6

2 938

1.1 %

13.4

15.61

188

2018-09-30
%

19 896

100

5 275

24.1

14 621

75.9

0

3 475

16.2

10 650

51.6

3 971

24.3

-74

-0.5

25

0.2

3 922

24

1 018

6.2

2 906

17.8

15.38

188.5

View Section: Balance Sheet